DongKoo Bio & Pharma Overview
- Founded
-
1970
- Status
-
Public
- Employees
-
370
- Stock Symbol
-
006620
- Share Price
-
$4.45
- (As of Friday Closing)
DongKoo Bio & Pharma General Information
Description
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.
Contact Information
Website
www.dongkoo.com
Formerly Known As
DongKoo Pharm
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
KRX
Primary Office
- 14F, Building B
- 114 Beobwon-ro, Songpa-g
- Seoul, Guro-gu
- South Korea
+82 00-0000-0000
DongKoo Bio & Pharma Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.45 | $4.53 | $3.62 - $6.68 | $123M | 27.6M | 103K | $0.18 |
DongKoo Bio & Pharma Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 138,304 | 138,304 | 187,125 | 211,191 |
| Revenue | 150,906 | 150,906 | 135,452 | 117,910 |
| EBITDA | 11,151 | 11,151 | 14,625 | 12,839 |
| Net Income | 5,119 | 5,119 | 8,143 | 7,742 |
| Total Assets | 136,240 | 136,240 | 130,070 | 132,323 |
| Total Debt | 27,177 | 27,177 | 20,415 | 21,764 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
DongKoo Bio & Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DongKoo Bio & Pharma Patents
DongKoo Bio & Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3466462-A1 | Medical injection device | Active | 25-May-2016 | 000000000 | |
| ES-2848728-T3 | Injection medical device | Active | 25-May-2016 | 00000000 | |
| JP-6529104-B1 | Medical infusion system | Active | 25-May-2016 | 000000000 | |
| JP-2019517897-A | Medical infusion system | Active | 25-May-2016 | 000000000 | |
| US-20190365988-A1 | Medical injection device | Active | 25-May-2016 | A61M5/168 | 0 |
DongKoo Bio & Pharma Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yong-Joon Cho | Chief Executive Officer |
DongKoo Bio & Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
